高危非复杂性B型主动脉夹层的血管内修复:系统综述与单臂荟萃分析
该系统综述与单臂荟萃分析纳入10项回顾性队列研究共1971例高危非复杂性B型主动脉夹层患者,评估TEVAR的早期和长期结局。汇总早期死亡率为1.22%,1年、3年、5年生存率分别为88.0%、84.0%、77.4%,主动脉重塑显示胸径平均缩小4.29 mm。结论认为TEVAR早期死亡率低、长期生存和主动脉重塑良好,但证据限于非随机研究。
要点
- TEVAR治疗hrTBAD汇总早期死亡率为1.22%,卒中3.29%,脊髓缺血1.10%。
- 长期生存率1年88.0%、3年84.0%、5年77.4%,再干预率6.63%。
- 晚期并发症包括逆行A型夹层2.27%、主动脉破裂2.63%、支架诱导新破口3.10%。
核心结论
- TEVAR在hrTBAD患者中与低早期死亡率和良好的长期生存及主动脉重塑相关,尤其在亚急性期进行时。
- 当前证据仅限于非随机研究,需要进一步前瞻性试验来优化患者选择和确定长期疗效。
研究设计与样本
- 系统综述与单臂荟萃分析,检索MEDLINE、Embase和Cochrane Library至2025年1月。
- 纳入10项回顾性队列研究,共1971例hrTBAD患者,采用随机效应模型合成数据,从Kaplan-Meier曲线重建个体患者数据估计汇总生存率。
主要发现
- 汇总早期死亡率为1.22%(95%CI 0.14%-2.96%),卒中3.29%,脊髓缺血1.10%,早期Stanford A型夹层0.40%。
- 晚期生存率1年88.0%、3年84.0%、5年77.4%;再干预率6.63%,异质性较大。
- 晚期并发症包括逆行A型夹层2.27%、主动脉破裂2.63%、支架诱导新破口3.10%。
- 主动脉重塑分析显示胸径平均缩小4.29 mm,假腔血栓形成率14.65%。
关键数值与推荐
- hrTBAD定义依据血管外科学会(SVS)标准。
- 汇总早期死亡率1.22%(95%CI 0.14%-2.96%),卒中3.29%,脊髓缺血1.10%,早期Stanford A型夹层0.40%。
- 晚期生存率1年88.0%、3年84.0%、5年77.4%;再干预率6.63%。
- 晚期并发症:逆行A型夹层2.27%、主动脉破裂2.63%、支架诱导新破口3.10%。
- 胸径平均缩小4.29 mm,假腔血栓形成率14.65%。
临床怎么用
- TEVAR可作为hrTBAD的治疗选择,尤其在亚急性期,但需权衡卒中、脊髓缺血、支架诱导新破口或逆行夹层等并发症风险。
- 在缺乏随机证据的情况下,TEVAR应基于个案考虑,整合解剖风险特征、机构经验和个体化预后评估,在多学科决策中确定。
局限性
- 当前证据仅限于非随机研究(回顾性队列)。
- 再干预率分析存在较大异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-risk features in patients with uncomplicated type B aortic dissection (hrTBAD) have been associated with adverse aortic events and poor prognosis when managed with optimal medical therapy (OMT) alone. However, the role of thoracic endovascular aortic repair (TEVAR) in this specific subgroup remains controversial. While some studies suggest that early endovascular intervention may improve long-term aortic remodeling and reduce late complications, others emphasize the potential procedural risks and lack of randomized evidence. To address these uncertainties, we conducted a systematic review and single-arm meta-analysis to evaluate the early and long-term outcomes of TEVAR in patients with hrTBAD. METHODS: We searched MEDLINE, Embase, and Cochrane Library through January 2025 for studies reporting outcomes of TEVAR in hrTBAD. Eligible studies were observational cohorts or trials including patients with hrTBAD, as defined by Society for Vascular Surgery criteria. Data were synthesized using random-effects models. Individual patient data were reconstructed from Kaplan-Meier curves to estimate pooled survival. RESULTS: Ten retrospective cohort studies involving 1971 patients were included. Pooled early mortality was 1.22% (95% confidence interval [CI], 0.14%-2.96%), stroke 3.29%, spinal cord ischemia 1.10%, and early Stanford type A dissection 0.40%. Late outcomes showed survival rates of 88.0% at 1 year, 84.0% at 3 years, and 77.4% at 5 years. Reintervention occurred in 6.63%, with considerable heterogeneity. Late complications included retrograde type A dissection (2.27%), aortic rupture (2.63%), and stent-induced new entry (3.10%). Aortic remodeling analysis revealed a mean thoracic diameter reduction of 4.29 mm and a false lumen thrombosis rate of 14.65%. CONCLUSION: Thoracic endovascular aortic repair in hrTBAD patients is associated with low early mortality and favorable long-term survival and aortic remodeling, especially when performed during the subacute phase. Despite encouraging results, current evidence is limited to non-randomized studies. Further prospective trials are needed to refine patient selection and determine long-term efficacy.Clinical ImpactThis meta-analysis reinforces that thoracic endovascular aortic repair (TEVAR) for high-risk uncomplicated type B aortic dissection (hrTBAD) is safe and potentially beneficial, demonstrating low early mortality and encouraging aortic remodeling outcomes. However, the procedure is not devoid of complications, such as stroke, spinal cord ischemia, stent-induced new entry (SINE), or retrograde dissection, which may be infrequent in conservatively managed patients. Until randomized evidence becomes available, TEVAR should be considered on a case-by-case basis, integrating anatomical risk profiles, institutional expertise, and individualized prognostic assessment within multidisciplinary decision-making.
引用
- Bohatch Júnior MS, de Melo Silva B, Soares EAG, et al. Endovascular Repair in High-Risk Uncomplicated Type B Aortic Dissection: A Systematic Review and Single-Arm Meta-Analysis. J Endovasc Ther. 2026. PMID: 41578935. doi:10.1177/15266028251408978
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。